Search results for "MAINTENANCE"

showing 10 items of 392 documents

Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction…

2005

Desired adjustment of methadone dose, perceived participation in dosage regulation, and satisfaction with methadone treatment centres were assessed in a sample of opioid-dependent patients from the Valencia Region (eastern Spain). An independent interviewer asked 278 consecutively arriving patients to answer the survey, and 165 (59.4%) completed it. Adjustment of methadone dose was assessed with a -10 to +10 visual analogue scale (VAS-MD); participation in methadone dose regulation, with specific questions; and patient satisfaction, with the Verona Service Satisfaction Scale for methadone treatment (VSSS-MT). The methadone dose (mg/d) prescribed by physicians was (mean+/-S.D.) 68.0+/-30.4. …

AdultMalemedicine.medical_specialtyMethadone maintenanceAdolescentVisual analogue scalemedia_common.quotation_subjectPersonal SatisfactionToxicologyDrug Administration ScheduleHeroinPatient satisfactionDose adjustmentInternal medicinemedicineHumansPharmacology (medical)Patient participationPsychiatrymedia_commonPharmacologybusiness.industryHeroin DependenceAddictionMiddle AgedOpioid-Related DisordersPsychiatry and Mental healthSpainFemaleHealth Services ResearchPatient ParticipationbusinessAttitude to HealthMethadonemedicine.drugMethadoneDrug and alcohol dependence
researchProduct

Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis

2018

ObjectiveTo investigate clinical and radiological outcomes of women with relapsing-remitting multiple sclerosis (RRMS) undergoing abortion.MethodsAn independent, multicentre retrospective study was conducted collecting data from eight Italian MS centres. We compared the preconception and postabortion annualised relapse rate (ARR) and number of Gadolinium enhancing (Gd+) lesions, by analyses of covariance. Variables associated with postabortion clinical and MRI activity were investigated using Poisson regression models; each abortion was considered as a statistical unit.ResultsFrom 1995 to 2017, we observed 188 abortions (17 elective) in 153 women with RRMS. Abortions occurred after a mean t…

AdultMalemedicine.medical_specialtyMultiple SclerosisGadoliniumNeuroimagingDiseaseRelapsing-RemittingAbortionSettore MED/26annualised relapse rateYoung Adult03 medical and health sciencessymbols.namesakeMultiple Sclerosis Relapsing-Remitting0302 clinical medicineRecurrencemedicineHumansPoisson regressionRetrospective StudiesInflammationPregnancy030219 obstetrics & reproductive medicinebusiness.industryObstetricsMultiple sclerosisInducedAbortionAbortion InducedRetrospective cohort studymedicine.diseaseMagnetic Resonance Imaginggadolinium enhancing lesionDiscontinuationPsychiatry and Mental healthPregnancy Maintenancemultiple sclerosisymbolsSettore MED/26 - NeurologiaFemaleSurgerypregnancyNeurology (clinical)business030217 neurology & neurosurgeryabortion; annualised relapse rate; gadolinium enhancing lesion; multiple sclerosis; pregnancyJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders

2019

Abstract Objective To evaluate disease activity according to rituximab (RTX) induction and maintenance regimens in a multicenter real-life dataset of NMOSD patients. Methods This is an observational-retrospective multicentre study including patients with NMOSD treated with RTX in 21 Italian and 1 Swiss centers. Demographics, relapse rate and adverse events over the follow-up were summarized taking into account induction strategy (two-1 g infusions at a 15-day interval (IND-A) vs. 375 mg/m2/week infusions for one month (IND-B)) and maintenance therapy (regimen A (M-A) with fixed time-points infusions vs. regimen B (M-B) based on cytofluorimetric driven reinfusion regimens, the least further …

AdultMalemedicine.medical_specialtyMultivariate analysisEfficacyOutcome and Process AssessmentSettore MED/2603 medical and health sciences0302 clinical medicineMaintenance therapyInternal medicinemedicineHumansImmunologic FactorsIn patient030212 general & internal medicineAdverse effectAgedRetrospective StudiesNeuromyelitis opticabusiness.industryMultiple sclerosisGeneral MedicineMiddle Agedmedicine.diseaseNeuromyelitis opticaHealth CareRegimenOutcome and Process Assessment Health CareNeurologyEfficacy Neuromyelitis optica RituximabRituximabFemaleNeurology (clinical)businessRituximab030217 neurology & neurosurgerymedicine.drugFollow-Up Studies
researchProduct

Personalized goal for insomnia and clinical response in advanced cancer patients.

2019

Aim: The aim of this study was to assess the Personalized Insomnia Intensity Goal (PIIG), the achievement of Personalized Goal Response (PGR), and Patient Global Impression (PGI) after a comprehensive symptom management. Patients and methods: Advanced cancer patients admitted to palliative care units rated pain and symptoms intensity and their PIIG by using the Edmonton Symptom Assessment Score (ESAS) (T0). In patients with significant levels of insomnia, the achievement of target expected (PIIG) was measured (patient goal response, PIGR), as well the patient global impression (PGI), by the minimal clinically important difference (MCID), after a comprehensive symptom management (T7). Result…

AdultMalemedicine.medical_specialtyPalliative careInsomniaDecision MakingPainSymptom assessmentGlobal impression of change03 medical and health sciences0302 clinical medicineInternal medicineAdvanced cancerNeoplasmsSleep Initiation and Maintenance DisordersInsomniamedicineHumansPain ManagementIn patient030212 general & internal medicineAgedAged 80 and overSymptom managementbusiness.industryMinimal clinically important differencePalliative CareMiddle AgedAdvanced cancerIntensity (physics)HospitalizationOncology030220 oncology & carcinogenesisPersonalized symptom goalFemalemedicine.symptomSymptom AssessmentbusinessGoalsSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
researchProduct

Thiopurine adherence: high prevalence with low impact in UC outcomes

2021

Introduction Thiopurines are used as maintenance therapy in patients with ulcerative colitis (UC). There are contradictory results regarding the relationship between adherence to treatment and risk of relapse. Objectives To quantify and evaluate the trends in thiopurines prescription rates, and to determine the impact and risk factors of non-adherence. Methods Analytical, observational and retrospective study of UC patients, on thiopurines, included in the ENEIDA single-center registry from October 2017 to October 2019. We included adult patients under clinical remission at the beginning of the study on thiopurines maintenance treatment for at least 6 months before recruitment. Adherence wa…

AdultMalemedicine.medical_specialtyPharmacyMaintenance therapyRecurrenceInternal medicineAzathioprinePrevalencemedicineHumansMedical prescriptionRetrospective StudiesThiopurine methyltransferasebiologyMercaptopurinebusiness.industryGastroenterologyRetrospective cohort studyGeneral Medicinemedicine.diseaseUlcerative colitisConcomitantbiology.proteinColitis UlcerativeFemaleObservational studybusinessRevista Española de Enfermedades Digestivas
researchProduct

Examination and treatment of sleep-related painful erections--a case report.

1989

The case of a patient with sleep-related painful erections is described. Insomnia and a slight depressive syndrome occurred along with a long history of this disorder. No physical abnormality was found. At a baseline recording of sleep electroencephalography (EEG) and nocturnal penile tumescence (NPT), a disturbed sleep pattern and impaired NPT were recorded. Attempts to treat the disorder with diazepam, amitriptyline, trimipramine, and biperidene did not prompt a stable improvement of the disorder, but a dosage of 25 mg clozapine was sufficient to achieve normalized sleep architecture, remission of the depressive symptomatology, and normalization of NPT. It is likely that marked sedation i…

AdultMalemedicine.medical_specialtySedationAdministration OralPainElectroencephalographyArts and Humanities (miscellaneous)DibenzazepinesSleep Initiation and Maintenance DisordersInsomniamedicineHumansAmitriptylinePsychiatryClozapineEvoked PotentialsGeneral PsychologyClozapinemedicine.diagnostic_testPenile ErectionElectroencephalographyTrimipramineNocturnal penile tumescenceAnesthesiaDisturbed sleep patternSleep Stagesmedicine.symptomPsychologymedicine.drugArchives of sexual behavior
researchProduct

A breathing-retraining procedure in treatment of sleep-onset insomnia: theoretical basis and experimental findings.

1995

Increase in CO2 has a sedative effect upon the central nervous system, and the beginning of sleep coincides with modifications in breathing, decrease in ventilation, and in pCO2 increase. In this paper is described a technique of breathing that is useful in producing drowsiness in a very short time. 46 insomniacs were randomly allocated to either a treatment or control condition. In the former, patients were trained in the breathing process. The control group was taught no breathing process. Latencies to sleep for the insomniacs confirmed that the breathing process was useful in producing drowsiness. Theoretical bases are discussed.

AdultMalemedicine.medical_specialtySedative effectExperimental and Cognitive PsychologyBreathing Exercises050105 experimental psychologylaw.invention03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationRandomized controlled triallawSleep Initiation and Maintenance DisordersmedicineInsomniaHumans0501 psychology and cognitive sciencesBreathing retrainingdigestive oral and skin physiology05 social sciences030229 sport sciencesCarbon DioxideSensory SystemsAnesthesiaBreathingFemaleSleep (system call)Sleep Stagesmedicine.symptomSleep onsetPsychologyArousalPerceptual and motor skills
researchProduct

Pharmacokinetics of atenolol in relation to renal function

1981

The plasma levels and urinary excretion of carteolol and its main metabolites 8-hydroxycarteolol and carteolol glucuronide were investigated in 6 healthy subjects and 9 patients with varying degrees of renal impairment following a single oral dose of 30 mg carteolol hydrochloride. In healthy subjects the half-life of carteolol was 7.1 h. 63% of the administered dose was recovered unchanged in urine, and in all 84% was excreted by the kidneys. The renal clearance of carteolol was 255 ml/min. In chronic renal failure (CRF) the terminal half-life was increased to a maximum of 41 h. Both the elimination rate constant and renal clearance were closely related to the creatinine clearance. In CRF t…

AdultMalemedicine.medical_specialtyUrologyAdministration OralRenal functionCarteolol HydrochloridePropanolamineschemistry.chemical_compoundPharmacokineticsElimination rate constantRenal DialysisInternal medicinemedicineHumansPharmacology (medical)CarteololAgedPharmacologyKidneyCreatinineMaintenance dosebusiness.industryGeneral MedicineMiddle AgedKineticsEndocrinologymedicine.anatomical_structureAtenololchemistryInjections IntravenousFemaleKidney DiseasesbusinessGlomerular Filtration Ratemedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Associations of disordered sleep with body fat distribution, physical activity and diet among overweight middle-aged men

2015

This cross-sectional study aimed to investigate whether body fat distribution, physical activity levels and dietary intakes are associated with insomnia and/or obstructive sleep apnea among overweight middle-aged men. Participants were 211 Finnish men aged 30-65 years. Among the 163 overweight or obese participants, 40 had insomnia only, 23 had obstructive sleep apnea only, 24 had comorbid insomnia and obstructive sleep apnea and 76 were without sleep disorder. The remaining 48 participants had normal weight without sleep disorder. Fat mass, levels of physical activity and diet were assessed by dual-energy X-ray densitometry, physical activity questionnaire and 3-day food diary, respectivel…

AdultMalemedicine.medical_specialtyinsomniaCognitive Neurosciencephysical activityComorbidityMotor ActivityOverweightBody Mass IndexOSABehavioral NeuroscienceFolic AcidSleep Initiation and Maintenance DisordersSurveys and QuestionnairesInternal medicinemedicineInsomniaBody Fat DistributionHumansObesityExerciseFinlandAdiposityAgedSleep Apnea ObstructiveSleep disorderbusiness.industrySleep apneaApneata3141dietary intakesFeeding BehaviorGeneral MedicineMiddle AgedOverweightmedicine.diseaseDietary FatsObesityDietObstructive sleep apneaCross-Sectional Studiesfat distributionObesity AbdominalPhysical therapymedicine.symptombusinessBody mass indexJournal of Sleep Research
researchProduct

Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease

2013

Background Nasal polyposis frequently occurs within the clinical picture of aspirin-exacerbated respiratory disease (AERD). A derailed arachidonic acid metabolism is regarded to be part of the pathophysiology of AERD, and aspirin desensitization is the only causal therapeutic option, so far. The optimal maintenance dose of aspirin desensitization to prevent nasal polyp recurrence on the one hand and to minimize aspirin-related side-effects, on the other hand, is still a matter of debate. The aim of this trial was to investigate the efficacy and safety of a low-dose aspirin desensitization protocol. Methods After sinus surgery, 70 individuals with AERD were randomly allocated to a prospectiv…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentImmunologylaw.inventionDrug HypersensitivityQuality of lifeRandomized controlled trialRecurrencelawSurveys and QuestionnairesInternal medicineRespiratory HypersensitivitymedicineHumansImmunology and AllergyDesensitization (medicine)AspirinAspirinMaintenance dosebusiness.industryRespiratory diseaseMiddle Agedmedicine.diseasePathophysiologyClinical trialTreatment OutcomeDesensitization ImmunologicAnesthesiaQuality of LifeFemalebusinessFollow-Up Studiesmedicine.drugAllergy
researchProduct